267 results on '"Flodström-Tullberg, Malin"'
Search Results
2. Intestinal stroma guides monocyte differentiation to macrophages through GM-CSF
3. Production, analysis, and safety assessment of a soil and plant-based natural material with microbiome- and immune-modulatory effects
4. Vemurafenib inhibits the replication of diabetogenic enteroviruses in intestinal epithelial and pancreatic beta cells
5. Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia
6. Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine
7. High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19
8. Coxsackievirus B infections are common in Cystic Fibrosis and experimental evidence supports protection by vaccination
9. Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine
10. Coxsackievirus B Persistence Modifies the Proteome and the Secretome of Pancreatic Ductal Cells
11. Mouse Models of Virus-Induced Type 1 Diabetes
12. New Coxsackievirus 2Apro and 3Cpro protease antibodies for virus detection and discovery of pathogenic mechanisms
13. Coxsackie B virus
14. Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence. Reply to Skog O, Klingel K, Roivainen M et al [letter]
15. Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
16. A Link Between a Common Mutation in CFTR and Impaired Innate and Adaptive Viral Defense
17. The Stromal Cell-Derived Factor-1α/CXCR4 Ligand-Receptor Axis Is Critical for Progenitor Survival and Migration in the Pancreas
18. Characterization of immune response towards modified Coxsackie B virus-like particle vaccine in a murine model
19. Genetic and Environmental Interaction in Type 1 Diabetes: a Relationship Between Genetic Risk Alleles and Molecular Traits of Enterovirus Infection?
20. Short-term CFTR inhibition reduces islet area in C57BL/6 mice
21. Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention
22. Application of bioinformatics in probe design enables detection of enteroviruses on different taxonomic levels by advanced in situ hybridization technology
23. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes
24. Proteome profiling of whole plasma and plasma-derived extracellular vesicles facilitates the detection of tissue biomarkers in the non-obese diabetic mouse
25. A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models
26. The Karolinska KI/K COVID-19 immune atlas: An open resource for immunological research and educational purposes
27. Loss of Parity between IL-2 and IL-21 in the NOD Idd3 Locus
28. Beta-cell specific expression of suppressor of cytokine signaling-1 (SOCS-1) delays islet allograft rejection by down-regulating Interferon Regulatory Factor-1 (IRF-1) signaling
29. Depletion of IL-2 receptor β-positive cells protects from diabetes in non-obese diabetic mice
30. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education
31. Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after Coxsackievirus infection
32. High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19
33. Natural killer cells in human autoimmunity
34. Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect
35. Chromogranin A Deficiency Confers Protection from Autoimmune Diabetes Via Multiple Mechanisms
36. Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect
37. Inhibition of Type III Interferon Expression in Intestinal Epithelial Cells-A Strategy Used by Coxsackie B Virus to Evade the Host's Innate Immune Response at the Primary Site of Infection?
38. Detection of enterovirus in the islet cells of patients with type 1 diabetes: what do we learn from immunohistochemistry? Reply to Hansson SF, Korsgren S, Pontén F et al [letter]
39. Suppressor of cytokine signaling-1 inhibits caspase activation and protects from cytokine-induced beta cell death
40. Proteome profiling of whole plasma and plasma-derived extracellular vesicles facilitates the detection of tissue biomarkers in the non-obese diabetic mouse.
41. Antibody Responses against Enterovirus Proteases are Potential Markers for an Acute Infection
42. Human enterovirus group B viruses rely on vimentin dynamics for efficient processing of viral nonstructural proteins
43. Interferons induce an antiviral state in human pancreatic islet cells
44. Inhibition of Type III Interferon Expression in Intestinal Epithelial Cells—A Strategy Used by Coxsackie B Virus to Evade the Host’s Innate Immune Response at the Primary Site of Infection?
45. Protection Against Type 1 Diabetes Upon Coxsackievirus B4 Infection and iNKT-Cell Stimulation: Role of Suppressive Macrophages
46. Corona Pandemic: Assisted Isolation and Care to Protect Vulnerable Populations May Allow Us to Shorten the Universal Lock-Down and Gradually Re-open Society
47. Defining the proteolytic landscape during enterovirus infection
48. Antibody Responses against Enterovirus Proteases are Potential Markers for an Acute Infection
49. Human Enterovirus Group B Viruses Rely on Vimentin Dynamics for Efficient Processing of Viral Nonstructural Proteins
50. Co-transplantation of Stromal Cells Interferes with the Rejection of Allogeneic Islet Grafts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.